PT  - JOURNAL ARTICLE
AU  - Thomas, MG
AU  - Mastorides, SM
AU  - Borkowski, SA
AU  - Reed, JR
AU  - Deland, LA
AU  - Thomas, LB
AU  - Borkowski, AA
TI  - Assessing Artificial Intelligence Models to Diagnose and Differentiate Common Liver Carcinomas
AID  - 10.1101/2022.08.30.22279347
DP  - 2022 Jan 01
TA  - medRxiv
PG  - 2022.08.30.22279347
4099  - http://medrxiv.org/content/early/2022/09/01/2022.08.30.22279347.short
4100  - http://medrxiv.org/content/early/2022/09/01/2022.08.30.22279347.full
AB  - The role of artificial intelligence (AI) in health care delivery is growing rapidly. Due to its visual nature, the specialty of anatomic pathology has great promise for applications in AI. We examine the potential of six different AI models for differentiating and diagnosing the three most common primary liver tumors: hepatocellular carcinoma (HCC), cholangiocarcinoma (CCA), and combined HCC and CCA (cHCC/CCA). Our results demonstrated that for all three diagnoses, the sensitivity, specificity, positive predictive value, and negative predictive value was ≥ 94% in the best model tested, with results ≥ 92% in all categories in three of the models. These values are comparable to interpretation by general pathologists alone and demonstrate AI’s potential in interpreting patient specimens for primary liver carcinoma. Applications such as these have multiple implications for delivering quality patient care, including assisting with intraoperative consultations and providing a rapid “second opinion” for confirmation and increased accuracy of final diagnoses. These applications may be particularly useful in underserved areas with shortages of subspecialized pathologists or after hours in larger medical centers. In addition, AI models such as these can decrease turnaround times and the inter- and intra-observer variability well documented in pathologic diagnoses. AI offers great potential in assisting pathologists in their day-to-day practice.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis material is the result of work supported with the resources and the use of facilities at the James A. Haley Veterans Hospital no external funding was utilized.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This work is approved by the University of South Florida Institutional Review Board (IRB # 541).I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors